Metrolina Internal Medicine
Charlotte, North Carolina, United States
Doctor in Charlotte, North Carolina
7945 N Tryon St # 112, Charlotte, NC 28262
About Metrolina Internal Medicine
"Metrolina Internal Medicine is an independently owned and privately operated practice proudly serving Charlotte for over 26 years. We specialize in the prevention, diagnosis and treatment of adult and non-surgical diseases, in addition to providing in-office preventive health screenings. Call us today."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
4
Bristol-Myers Squibb
4
Eli Lilly and Company
4
Gilead Sciences
2
Idorsia Pharmaceuticals Ltd.
2
Boehringer Ingelheim
1
Brigham and Women's Hospital
1
Daiichi Sankyo, Inc.
1
Eisai Inc.
1
Mannkind Corporation
1
Novartis
1
Clinical Trials at Metrolina Internal Medicine
During the past decade, Metrolina Internal Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 15 clinical trials were completed, i.e. on
average, 375% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
2005-09-01
2006-09-01
Completed
152
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
2006-04-01
2008-09-01
Completed
768
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
2004-12-01
Completed
547
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients
2007-06-01
2009-03-01
Completed
463
Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity
2008-07-01
2009-07-01
Completed
729
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Metrolina Internal Medicine" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Bristol-Myers Squibb" with 4 trials
sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Metrolina Internal Medicine"
#1 collaborator was "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Metrolina Internal Medicine
According to Clinical.Site data, the most researched conditions in "Metrolina Internal Medicine" are
"Hypertension" (5 trials), "Type 2 Diabetes" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Metrolina Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Metrolina Internal Medicine
Most popular intervention types in "Metrolina Internal Medicine" are "Drug" (22 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Dapagliflozin" (3 trials), "Saxagliptin" (3 trials), "Aprocitentan 25 mg" (2 trials) and "Darusentan" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Metrolina Internal Medicine
The vast majority of trials in "Metrolina Internal Medicine" are
23 trials for "All" genders.
Clinical Trials Status at Metrolina Internal Medicine
Currently, there are NaN active trials in "Metrolina Internal Medicine".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Metrolina Internal Medicine,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Metrolina Internal Medicine, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".